Atossa Therapeutics, Inc. (ATOS)
2.42
0.00 (0.00%)
USD |
NASDAQ |
Sep 17, 16:00
2.37
-0.05
(-2.07%)
After-Hours: 20:00
Atossa Therapeutics Market Cap : 24.15M for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 24.15M |
| September 15, 2026 | 23.65M |
| September 14, 2026 | 24.75M |
| September 11, 2026 | 25.05M |
| September 10, 2026 | 23.35M |
| September 09, 2026 | 23.95M |
| September 08, 2026 | 25.10M |
| September 04, 2026 | 25.15M |
| September 03, 2026 | 25.25M |
| September 02, 2026 | 24.55M |
| September 01, 2026 | 24.15M |
| August 31, 2026 | 24.95M |
| August 28, 2026 | 25.75M |
| August 27, 2026 | 26.35M |
| August 26, 2026 | 26.45M |
| August 25, 2026 | 26.74M |
| August 24, 2026 | 26.35M |
| August 21, 2026 | 25.35M |
| August 20, 2026 | 25.85M |
| August 19, 2026 | 26.35M |
| August 18, 2026 | 25.85M |
| August 17, 2026 | 27.84M |
| August 14, 2026 | 25.95M |
| August 13, 2026 | 25.55M |
| August 12, 2026 | 23.45M |
| Date | Value |
|---|---|
| August 11, 2026 | 23.55M |
| August 10, 2026 | 23.65M |
| August 07, 2026 | 23.55M |
| August 06, 2026 | 24.15M |
| August 05, 2026 | 23.85M |
| August 04, 2026 | 19.89M |
| August 03, 2026 | 18.69M |
| July 31, 2026 | 17.83M |
| July 30, 2026 | 18.86M |
| July 29, 2026 | 19.89M |
| July 28, 2026 | 20.80M |
| July 27, 2026 | 20.32M |
| July 24, 2026 | 19.76M |
| July 23, 2026 | 20.75M |
| July 22, 2026 | 20.93M |
| July 21, 2026 | 20.67M |
| July 20, 2026 | 21.44M |
| July 17, 2026 | 21.44M |
| July 16, 2026 | 20.58M |
| July 15, 2026 | 21.01M |
| July 14, 2026 | 19.46M |
| July 13, 2026 | 20.67M |
| July 10, 2026 | 20.41M |
| July 09, 2026 | 20.32M |
| July 08, 2026 | 21.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immix Biopharma, Inc. | 911.36M |
| ACADIA Pharmaceuticals, Inc. | 4.725B |
| Alnylam Pharmaceuticals, Inc. | 32.83B |
| Anika Therapeutics, Inc. | 280.91M |
| Savara, Inc. | 1.112B |
Market Cap Related Metrics
| PEG Ratio | -0.0041 |
| Price to Book Value | 0.9001 |
| Price | 2.42 |
| Earnings Yield | -179.5% |
| PEGY Ratio | -0.0041 |